Share
Market Research Report

NANOBODIES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeMonovalent Nanobodies · Bivalent Nanobodies · Bispecific Nanobodies · Biparatopic Nanobodies · Multivalent Nanobodies · Fusion Nanobodies
  • By Therapeutic AreaOncology · Infectious Diseases · Inflammatory and Autoimmune Diseases · Neurological Disorders · Others
  • By ApplicationTherapeutic · Diagnostic · Research
  • By End UserHospitals · Biopharmaceutical Companies · Diagnostic Laboratories · Others
  • By GeographyNorth America · Latin America · Europe · Middle East & Africa · and Asia Pacific
  • Published In28 Apr 2026
  • Report CodeCMI1680
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Therapeutic Area
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Recent Trends
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • PORTER’s Analysis
  4. Global Nanobodies Market, By Product Type, 2021– 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Monovalent Nanobodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Bivalent Nanobodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Bispecific Nanobodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Biparatopic Nanobodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Multivalent Nanobodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Fusion Nanobodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
  5. Global Nanobodies Market, By Therapeutic Area, 2021 – 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Inflammatory and Autoimmune Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Neurological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
  6. Global Nanobodies Market, By

    Application, 2021 – 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Therapeutic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Diagnostic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
    • Research
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
  7. Global Nanobodies Market, By End User, 2021 – 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
    • Biopharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
      • Segment Trends
  8. Global Nanobodies Market, By Region, 2021 – 2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Application, 2021–2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth, By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth, By Country,  2021–2033, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Application, 2021–2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth, By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth, By Country,  2021–2033, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Application, 2021–2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth, By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth, By Country,  2021–2033, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Application, 2021–2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth, By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth, By Country,  2021–2033, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Application, 2021–2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth, By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth, By Country,  2021–2033, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast,Y-o-Y Growth, By Product Type, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2021–2033, (US$ Mn)
      • Market Size and Forecast, Y-o-Y Growth, By Application, 2021–2033, (US$ Mn)
      • Market Size and Forecast,Y-o-Y Growth, By End User, 2021–2033, (US$ Mn)
      • Market Size and Forecast, By Country, Y-o-Y Growth, By Country,  2021–2033, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Company Profiles
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AlpalifeB Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • GenScript
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Novartis International AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Taisho Pharmaceutical Holdings Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sino Biological, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • GeneMedi
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Biocytogen
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Abnova Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • NanoTag Biotechnologies
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Avillion LLP
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Capra Science
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Numab Therapeutics
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • CUSABIO TECHNOLOGY LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Proteintech Group, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • GT Biopharma, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Confo Therapeutics
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • R&D Systems, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Abcepta Biotech Ltd. Co.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
    • Analysts’ Views
  10. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 44 market data tables and 41 figures on “Global Nanobodies Market” – Global forecast to 2033